← BioTransfer GEO Dataset Finder
GEO series

Single-Cell RNA-Seq Reveals Immunosuppressive Effects of Triple-Negative Breast Cancer–Derived Exosomes on NK Cell Responses

GSE303346 Homo sapiens Expression profiling by high throughput sequencing 16 samples Submitted 2026/07/25 Platform GPL34284
Summary
Triple-negative breast cancer (TNBC) is a highly aggressive and immunogenic subtype that lacks effective targeted therapies. Although tumor-derived exosomes are known to influence immune responses, their direct role in shaping human NK cell plasticity remains insufficiently characterized. In this study, we performed an integrative single-cell multiomic analysis of primary human NK cells following exposure to exosomes isolated from 17 genomically distinct TNBC cell lines. By combining single-cell transcriptomics, we identified conserved and subtype-specific immunoregulatory programs elicited by TNBC-derived exosomes.
This dataset
Download

Direct links to NCBI, no account and no request form: the whole study as GSE303346_RAW.tar, processed values as the series matrix, the supplementary file directory, and per-sample supplementary files for any of the 16 samples. Raw sequencing reads are also available from ENA.

Also filed as BioProject PRJNA1294879 and SRA study SRP602850. Searching any of these in the dataset finder brings you back here.

Study design
8 × Gene expression of NK cells samples treated by TNBC-exosomes and one untreated NK cells sample, Well vs 8 × ADT expression NK cells samples treated by TNBC-exosomes and one untreated NK cells sample, Well

Supports a between-group comparison across 16 samples.

2 replicated groups read from 16 sample titles; they account for 16 of them. Check it against the sample list below before relying on it.

Samples in this study
Similar datasets

Search all human RNA-seq datasets in GEO →

Share this dataset

Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.